EUVIMEDEUVIMED entdecken
Crossref

Chimeric Fab incorporating the IgM Cμ1 domain: insights into physicochemical properties

Rara Sugimoto, Masato Kiyoshi iD, Hitomi Nakamura, Naoko Oda-Ueda, Akiko Ishii-Watabe, Takatoshi Ohkuri iD

The Journal of Biochemistry · 2026

DOI: 10.1093/jb/mvag008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Biochemistry, 2026. Verfasst von Rara Sugimoto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Nishi-ku, Kumamoto 860-0082, Japan. Hauptthemen laut MEDLINE: Immunoglobulin Fab Fragments, Immunoglobulin M, Recombinant Fusion Proteins, Adalimumab. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fab has been extensively studied to elucidate the structural and physicochemical principles underlying antigen recognition. While most investigations have focused on IgG-derived Fabs, comparatively little is known about those from other isotypes. To investigate the role of the IgM constant domain Cμ1, we engineered a chimeric Fab (Cμ1Fab) in which the CH1 domain of adalimumab Fab (IgG1) was replaced by the human IgM Cμ1 domain. Cμ1Fab was expressed in CHO cells and its physicochemical properties were evaluated. SDS-PAGE analysis with or without PNGase F treatment demonstrated that the N166–N167–S168 motif was N-glycosylated. SPR analysis demonstrated that Cμ1Fab retained antigen-binding activity comparable to that of the wild-type Fab, and elimination of the glycosylation motif (N166A) did not alter binding affinity. Notably, N-linked glycosylation within the Cμ1 domain suppressed aggregation, whereas the N166A variant showed marked aggregation. DSC further revealed that the glycosylation affected thermal stability. The melting temperature (Tm) of the N166A variant was 60.5°C, substantially lower than that of the Cμ1Fab (Tm = 66.0°C), although Tm of the wild-type Fab was 75.2°C. Collectively, these findings establish the critical role of native Cμ1 N-linked glycosylation in Fab stability, offering new insights for antibody engineering.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin Fab FragmentsImmunoglobulin MRecombinant Fusion ProteinsAdalimumabAnimalsHumansCHO CellsGlycosylationCricetulusProtein Domains

Stichwörter der Autor:innen

FabIgMadalimumabmutation analysisthermal stability

Substanzen

Immunoglobulin Fab FragmentsImmunoglobulin MRecombinant Fusion ProteinsAdalimumab

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Nishi-ku, Kumamoto 860-0082, Japan.
  • Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan.

ORCID-Profile: Masato Kiyoshi, Takatoshi Ohkuri

Zitieren

APA

Sugimoto, R., Kiyoshi, M., Nakamura, H., Oda-Ueda, N., Ishii-Watabe, A., & Ohkuri, T. (2026). Chimeric Fab incorporating the IgM Cμ1 domain: insights into physicochemical properties. The Journal of Biochemistry. https://doi.org/10.1093/jb/mvag008

Vancouver

Sugimoto R, Kiyoshi M, Nakamura H, Oda-Ueda N, Ishii-Watabe A, Ohkuri T. Chimeric Fab incorporating the IgM Cμ1 domain: insights into physicochemical properties. The Journal of Biochemistry. 2026. doi:10.1093/jb/mvag008

BibTeX
@article{Sugimoto2026,
  author = {Sugimoto, Rara and Kiyoshi, Masato and Nakamura, Hitomi and Oda-Ueda, Naoko and Ishii-Watabe, Akiko and Ohkuri, Takatoshi},
  title = {Chimeric Fab incorporating the IgM Cμ1 domain: insights into physicochemical properties},
  journal = {The Journal of Biochemistry},
  year = {2026},
  doi = {10.1093/jb/mvag008}
}
Kostenlos starten →